TSVT 2seventy bio
- 4.720
- -0.080-1.67%
- 4.976
- +0.256+5.41%
2seventy bio News
Analysts' Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy Bio (TSVT) and Repare Therapeutics (RPTX)
Morgan Stanley Maintains 2seventy Bio(TSVT.US) With Hold Rating, Maintains Target Price $6
Analysts Offer Insights on Healthcare Companies: 2seventy Bio (TSVT), Illumina (ILMN) and Larimar Therapeutics (LRMR)
Leerink Partners Keeps Their Buy Rating on 2seventy Bio (TSVT)
Hold Rating on 2seventy Bio: Balancing Modest Sales Growth Against Competitive Market Pressures
2seventy Bio Analyst Ratings
Morgan Stanley Maintains 2seventy Bio(TSVT.US) With Hold Rating, Cuts Target Price to $6
Analysts Offer Insights on Healthcare Companies: 2seventy Bio (TSVT) and Abbott Laboratories (ABT)
2seventy Bio Analyst Ratings
Buy Rating Affirmed for 2seventy Bio on Strong Growth Prospects and Financial Stability
2seventy Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA), 2seventy Bio (TSVT) and Marinus (MRNS)
Leerink Partners Sticks to Their Buy Rating for 2seventy Bio (TSVT)
2seventy Bio Analyst Ratings
Positive Outlook for 2seventy Bio's ABECMA: Buy Rating Affirmed Amidst Expansion and Competitive Dynamics
Buy Rating and High Risk for 2seventy Bio: FDA Approval and Market Expansion Fuel Optimistic Outlook
2seventy Bio Analyst Ratings
TD Cowen Sticks to Its Hold Rating for 2seventy Bio (TSVT)
Analysts Are Bullish on These Healthcare Stocks: 2seventy Bio (TSVT), Immuneering (IMRX)
TD Cowen Sticks to Their Hold Rating for 2seventy Bio (TSVT)
Analysis
Price Target
No Data
No Data